Beijing Wantai Biological Pharmacy (603392.SH) Reports First-Half Results, Swings to Loss of 144 Million Yuan

Stock News08-20

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) released its 2025 interim report, showing operating revenue of 844 million yuan, a decrease of 38.25% year-over-year. The company recorded a net loss attributable to shareholders of 144 million yuan. The adjusted net loss attributable to shareholders, excluding non-recurring items, reached 243 million yuan. Basic loss per share was 0.11 yuan. The decline in operating revenue was primarily attributed to the company's vaccine segment being impacted by market adjustments, government procurement policies, and the age expansion of the nine-valent HPV vaccine, resulting in sales falling short of expectations and causing vaccine segment revenue to drop compared to the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160674818?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-20 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160674818","market":"hk","top_or_hot":-1,"title":"Beijing Wantai Biological Pharmacy (603392.SH) Reports First-Half Results, Swings to Loss of 144 Million Yuan","media":"Stock News","content":"<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) released its 2025 interim report, showing operating revenue of 844 million yuan, a decrease of 38.25% year-over-year. The company recorded a net loss attributable to shareholders of 144 million yuan. The adjusted net loss attributable to shareholders, excluding non-recurring items, reached 243 million yuan. Basic loss per share was 0.11 yuan. The decline in operating revenue was primarily attributed to the company's vaccine segment being impacted by market adjustments, government procurement policies, and the age expansion of the nine-valent HPV vaccine, resulting in sales falling short of expectations and causing vaccine segment revenue to drop compared to the same period last year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Wantai Biological Pharmacy (603392.SH) Reports First-Half Results, Swings to Loss of 144 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Wantai Biological Pharmacy (603392.SH) Reports First-Half Results, Swings to Loss of 144 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-20 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) released its 2025 interim report, showing operating revenue of 844 million yuan, a decrease of 38.25% year-over-year. The company recorded a net loss attributable to shareholders of 144 million yuan. The adjusted net loss attributable to shareholders, excluding non-recurring items, reached 243 million yuan. Basic loss per share was 0.11 yuan. The decline in operating revenue was primarily attributed to the company's vaccine segment being impacted by market adjustments, government procurement policies, and the age expansion of the nine-valent HPV vaccine, resulting in sales falling short of expectations and causing vaccine segment revenue to drop compared to the same period last year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1589","symbol_name":"北水核心资产","start_time":0,"source_url":"","article_id":"1160674818","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160674818","pubTimestamp":1755681632,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) released its 2025 interim report, showing operating revenue of 844 million yuan, a decrease of 38.25% year-over-year. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603392":"万泰生物","BK1589":"北水核心资产","BK0239":"医药制造","09633":"农夫山泉","LU1981816686.USD":"EASTSPRING INV ASIAN MULTI FACTOR EQUITY \"A\" (USD) ACC","BK1200":"软饮料"},"translate_title":"北京万泰生物大药房（603392.SH）上半年业绩扭亏1.44亿元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603392":1,"09633":1},"content_text":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) released its 2025 interim report, showing operating revenue of 844 million yuan, a decrease of 38.25% year-over-year. The company recorded a net loss attributable to shareholders of 144 million yuan. The adjusted net loss attributable to shareholders, excluding non-recurring items, reached 243 million yuan. Basic loss per share was 0.11 yuan. The decline in operating revenue was primarily attributed to the company's vaccine segment being impacted by market adjustments, government procurement policies, and the age expansion of the nine-valent HPV vaccine, resulting in sales falling short of expectations and causing vaccine segment revenue to drop compared to the same period last year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160674818","isCrawlerRequest":true}